Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
EJNMMI Research|January 5, 2020
Early response monitoring of neoadjuvant chemotherapy using [<sup>18</sup>F]FDG PET can predict the clinical outcome of extremity osteosarcomaInki Lee, Byung Hyun Byun, Ilhan Lim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 15, 2013
Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcomaByung Hyun Byun, Chang-Bae Kong, Ilhan Lim, et al.
Annals of Surgical Oncology|January 12, 2011
Tumor volume increase during preoperative chemotherapy as a novel predictor of local recurrence in extremity osteosarcomaWon Seok Song, Dae-Geun Jeon, Chang-Bae Kong, et al.
Japanese Journal of Clinical Oncology|June 2, 2010
Soft-tissue Ewing sarcoma in a low-incidence population: comparison to skeletal Ewing sarcoma for clinical characteristics and treatment outcomeJun Ah Lee, Dong Ho Kim, Jung Sub Lim, et al.
Skeletal Radiology|September 3, 2013
Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcomaByung Hyun Byun, Chang-Bae Kong, Ilhan Lim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2013
¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcomaChang-Bae Kong, Byung Hyun Byun, Ilhan Lim, et al.
Korean Journal of Pediatrics|November 14, 2013
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in the treatment of children and adolescents with Ewing sarcoma family of tumorsJuhee Seo, Dong Ho Kim, Jung Sub Lim, et al.
European Radiology|February 15, 2015
Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CTByung Hyun Byun, Sung Hoon Kim, Sang Moo Lim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 22, 2014
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRIByung Hyun Byun, Chang-Bae Kong, Ilhan Lim, et al.
Oncology Letters|April 4, 2024
Secondary hematological malignancies in patients with sarcoma: A single‑center retrospective studyYoon Jung Jang, Hong Kyu Jeong, Chang-Bae Kong, et al.
Pageof 9